EW Healthcare Partners LP, 10% Owner at EyePoint Pharmaceuticals (NASDAQ:EYPT), reported a large insider sell on September 6, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that LP sold 20,000 shares of EyePoint Pharmaceuticals. The total transaction amounted to $197,982.
EyePoint Pharmaceuticals shares are trading up 0.74% at $9.84 at the time of this writing on Thursday morning.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
Why Insider Transactions Are Important
Insider transactions shouldn't be used ...